Dr Joshua Quick

Josh is a UKRI Future Leaders Fellow at the University of Birmingham developing novel methods for rapid antimicrobial resistance (AMR) prediction. He is a molecular biologist specialising in next-generation sequencing and has worked on both bacterial genomics and viral surveillance for outbreaks. He travelled to Guinea in West Africa and established the first mobile laboratory using nanopore sequencing to perform viral surveillance during the West African Ebola virus epidemic. He also developed amplicon-based sequencing method for low-titre clinical samples which has been widely adopted against Ebola, Zika, Yellow fever and SARS-CoV-2. He is currently focusing on bacterial single-cell technology as an approach to tackle the growing threat of resistance by rapidly identifying resistance genes in complex sample types such as clinical samples.